[Federal Register Volume 86, Number 247 (Wednesday, December 29, 2021)]
[Rules and Regulations]
[Page 73969]
[FR Doc No: 2021-28158]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 73

[Docket No. FDA-2018-C-0617]

Listing of Color Additives Exempt From Certification; Silver
Nitrate; Confirmation of Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or we) is confirming the
effective date of November 8, 2021, for the final rule that appeared in
the Federal Register of October 6, 2021, and that amended the color
additive regulations to provide for the safe use of silver nitrate as a
color additive in professional-use only cosmetics to color eyebrows and
eyelashes.

DATES: Effective date of final rule published in the Federal Register
of October 6, 2021 (86 FR 55494) confirmed: November 8, 2021.

ADDRESSES: For access to the docket to read background documents or
comments received, go to https://www.regulations.gov and insert the
docket number found in brackets in the heading of this final rule into
the ``Search'' box and follow the prompts, and/or go to the Dockets
Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Rachel Morissette, Center for Food
Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus
Dr., College Park, MD 20740,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: In the Federal Register of October 6, 2021
(86 FR 55494), we amended the color additive regulations in Sec.
73.2550 (21 CFR 73.2550), ``Silver nitrate,'' to provide for the safe
use of silver nitrate as a color additive in professional-use only
cosmetics to color eyebrows and eyelashes.
    We gave interested persons until November 5, 2021, to file
objections or requests for a hearing. We received no objections or
requests for a hearing on the final rule. Therefore, we find that the
effective date of the final rule that published in the Federal Register
of October 6, 2021, should be confirmed.

List of Subjects in 21 CFR Part 73

    Color additives, Cosmetics, Drugs, Foods, Medical devices.
    Therefore, under the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 321, 341, 342, 343, 348, 351, 352, 355, 361, 362, 371, 379e) and
under authority delegated to the Commissioner of Food and Drugs, we are
giving notice that no objections or requests for a hearing were filed
in response to the October 6, 2021, final rule. Accordingly, the
amendments issued thereby became effective November 8, 2021.

    Dated: December 21, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021-28158 Filed 12-28-21; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 79, Number 215 (Thursday, November 6, 2014)]
[Notices]
[Pages 66025-66026]
[FR Doc No: 2014-26386]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Agency Information Collection Activities: Requests for Comments;
Clearance of Renewed Approval of Information Collection: Commercial
Space Transportation Licensing Regulations

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FAA
invites public comments about our

intention to request the Office of Management and Budget (OMB) approval
to renew an information collection. The Federal Register Notice with a
60-day comment period soliciting comments on the following collection
of information was published on September 3, 2014, vol. 79, no. 170,
pages 52405-52406. The information will determine if applicant
proposals for conducting commercial space launches can be accomplished
according to regulations issued by the Office of the Associate
Administrator for Commercial Space Transportation.

DATES: Written comments should be submitted by December 8, 2014.

FOR FURTHER INFORMATION CONTACT: Kathy DePaepe at<PHONE_NUMBER>, or by
email at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:
    OMB Control Number: 2120-0608.
    Title: Commercial Space Transportation Licensing Regulations.
    Form Numbers: FAA Form 8800-1.
    Type of Review: Renewal of an information collection.
    Background: The Commercial Space Launch Act of 1984, 49 U.S.C. App.
2601--2623, as recodified at 49 U.S.C. Subtitle IX, Ch. 701--Commercial
Space Launch Activities, 49 U.S.C. 70101-70119 (1994), requires certain
data be provided in applying for a license to conduct commercial space
launch activities. These data are required to demonstrate to the
Federal Aviation Administration (FAA), Associate Administrator for
Commercial Space Transportation (AST), that a license applicant's
proposed activities meet applicable public safety, national security,
and foreign policy interests of the United States.
    Respondents: Approximately 4 space launch applicants.
    Frequency: Information is collected on occasion.
    Estimated Average Burden per Response: 1544.5 hours.
    Estimated Total Annual Burden: 6,178 hours.

ADDRESSES: Interested persons are invited to submit written comments on
the proposed information collection to the Office of Information and
Regulatory Affairs, Office of Management and Budget. Comments should be
addressed to the attention of the Desk Officer, Department of
Transportation/FAA, and sent via electronic mail to
<EMAIL_ADDRESS>or faxed to<PHONE_NUMBER>, or mailed to
the Office of Information and Regulatory Affairs, Office of Management
and Budget, Docket Library, Room 10102, 725 17th Street NW.,
Washington, DC 20503.
    Public Comments Invited: You are asked to comment on any aspect of
this information collection, including (a) Whether the proposed
collection of information is necessary for FAA's performance; (b) the
accuracy of the estimated burden; (c) ways for FAA to enhance the
quality, utility and clarity of the information collection; and (d)
ways that the burden could be minimized without reducing the quality of
the collected information. The agency will summarize and/or include
your comments in the request for OMB's clearance of this information
collection.

    Issued in Washington, DC, on November 3, 2014.
Albert R. Spence,
FAA Assistant Information Collection Clearance Officer, IT Enterprises
Business Services Division, ASP-110/.
[FR Doc. 2014-26386 Filed 11-5-14; 8:45 am]
BILLING CODE 4910-13-P


From: "Terry Schimmel (Bricks - Phenix City)"<EMAIL_ADDRESS>Sent: 08/13/2008 05:28 PM
To: Jeff Telander/RTP/USEPA/US@EPA
Cc:
Subject: Boral MACT ICR

Jeff,

Attached please find an electronic copy of Boral's completed ICR. Please note that the facility HAP classifications listed on FORM A are based on their current status. We will likely be reviewing the status of each facility in the coming years.
You will note that two of our facilities were not operated last year  These idled kilns remain functional and will be restarted when warranted. In addition, many of our kilns were not operated the entire year of 2007. I wish business conditions were better as so far it looks like our capacity utilization for 2008 is shaping up to be worse than 2007. Projections into the future look like several more years of hard times with expectation that demand may never get back to 2006 levels.
While year-round operation is typical for our industry, we have been impacted by the tough economic conditions of the past few years- and expect that this will continue for some time. This non-continuous operation obviously increases the cost of the control per ton of bricks produced, while also reducing the total profit that our company makes. We are interested in working with you and your economics lead (Tom Walton) to ensure that these conditions are included in your assessment of the impacts of any future rulemaking.
The non-continuous operation of our kilns and associated controls also creates additional maintenance and operating burdens. These additional activities are needed to ensure that the lime/limestone in our control devices are not permanently corrupted as the temperature within the chamber drops- and moisture from the atmosphere is introduced.
The throughputs/capacities listed on FORM B are based on yearly average throughputs. As we discussed during the site visits, the "capacity" of a brick kiln is not generally a stagnant number. We believe that you should not consider the "9.9" tph capacities when evaluating the control level at various sizes. These limits are not attributable to anything except the now vacated MACT. We are submitting FORM F under the CBI procedures you outlined. We are also mailing you the test reports listed via FedEx.
Please feel free to call me regarding the information on this submission or anything we may have missed. It's a pretty big task to complete this thing with as many plants as we have and I'm sure we may have missed something. Also in my capacity as the MACT Task Force lead person just let me know when and how we can help you all in ciphering through some of this information. Some of the questions have required some interpretation and everyone may not have understood what was being asked quite the same.

We look forward to working with you and all your people on the rule making.

Thanks,
Terry

(See attached file: Brick ICR- Boral- FINAL.xls)


[Federal Register Volume 88, Number 224 (Wednesday, November 22, 2023)]
[Notices]
[Page 81529]
[FR Doc No: 2023-25764]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Docket No. FAA-2023-2226]

Notice of Intent To Designate as Abandoned Supplemental Type
Certificate No. SA3-483

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of intent to Designate Supplemental Type Certificate as
abandoned; request for comments.

-----------------------------------------------------------------------

SUMMARY: This Notice announces the FAA's intent to designate
Supplemental Type Certificate (STC) No. SA3-483 as abandoned and make
the related engineering data available upon request. The FAA has
received a request to provide engineering data concerning this STC. The
FAA has been unsuccessful in contacting the STC holder concerning the
STC. This action is intended to enhance aviation safety.

DATES: We must receive all comments by May 20, 2024.

ADDRESSES: You may send comments on this notice by any of the following
methods:
     Federal eRulemaking Portal: Go to regulations.gov. Follow
the instructions for submitting comments.
     Mail: JoWanna Jenkins, Program Management Specialist,
Central Certification Branch (Chicago), 2300 East Devon Avenue, Room
107, Des Plaines, IL 60018.
     Email: [email protected]. Include ``Docket No. FAA-
2023-2226'' in the subject line of the message.
     Hand Delivery: Deliver to Mail address above between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.

FOR FURTHER INFORMATION CONTACT: JoWanna Jenkins, Program Management
Specialist, Central Certification Branch (Chicago), 2300 East Devon
Avenue, Room 107, Des Plaines, IL 60018; telephone<PHONE_NUMBER>; email
[email protected].

SUPPLEMENTARY INFORMATION:

Comments Invited

    The FAA invites interested parties to provide comments, written
data, views, or arguments relating to this notice. Send your comments
to an address listed under the ADDRESSES section. Include ``Docket No.
FAA-2023-2226'' at the beginning of your comments. The FAA will
consider all comments received on or before the closing date. All
comments received will be available in the docket for examination by
interested persons.

Background

    The FAA is posting this notice to inform the public of the intent
to designate as abandoned STC No. SA3-483, which installs a Continental
Model C85-12 engine on a Mooney Model M-18C 55 airplane, and
subsequently release the related engineering data.
    The FAA has received a third-party request for the release of the
aforementioned engineering data under the provisions of the Freedom of
Information Act (FOIA), 5 U.S.C. 552. The FAA cannot release commercial
or financial information under FOIA without the permission of the data
owner. However, in accordance with title 49 of the United States Code
section 44704(a)(5), the FAA can provide STC ``engineering data'' it
possesses for STC maintenance or improvement, upon request, if the
following conditions are met:
    1. The FAA determines the STC has been inactive for three years or
more;
    2. Using due diligence, the FAA is unable to locate the owner of
record or the owner of record's heir; and
    3. The availability of such data will enhance aviation safety.
    There has been no activity with this STC holder for more than three
years.
    On August 24, 2023, the FAA sent a registered letter to the STC
holder, Donna R. Sparks, at her last known address, 6414 East 86th
Street, Kansas City, MO 64138. The letter informed Ms. Sparks that the
FAA had received a request for engineering data related to STC No. SA3-
483 and was conducting a due diligence search to determine whether the
STC was inactive and may be considered abandoned. The letter further
requested Ms. Sparks to respond in writing within 60 days and state
whether she is the holder of the STC. The FAA also attempted to contact
Ms. Sparks by other means, including telephone communication, email,
and certified mail, without success.

Information Requested

    If you are the owner or heir or a transferee of STC No. SA3-483 or
have any knowledge regarding who may now hold STC No. SA3-483, please
contact JoWanna Jenkins using a method described in this notice under
FOR FURTHER INFORMATION CONTACT. If you are the heir of the owner, or
the owner by transfer, of STC No. SA3-483, you must provide a notarized
copy of your government-issued identification with a letter and
background establishing your ownership of the STC and, if applicable,
your relationship as the heir to the deceased holder of the STC.

Conclusion

    If the FAA does not receive any response by May 20, 2024, the FAA
will consider STC No. SA3-483 abandoned, and the FAA will proceed with
the release of the requested data. This action is for the purpose of
maintaining the airworthiness of an aircraft and enhancing aviation
safety.

    Issued on November 16, 2023.
Ross Landes,
Deputy Director for Regulatory Operations, Compliance & Airworthiness
Division, Aircraft Certification Service.
[FR Doc. 2023-25764 Filed 11-21-23; 8:45 am]
BILLING CODE 4910-10-P


[Federal Register Volume 82, Number 212 (Friday, November 3, 2017)]
[Notices]
[Pages 51311-51312]
[FR Doc No: 2017-23923]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-81977; File No. SR-NYSEArca-2017-36]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of
Designation of Longer Period for Commission Action on Proceedings To
Determine Whether To Approve or Disapprove a Proposed Rule Change To
Adopt NYSE Arca Equities Rule 8.900 To Permit Listing and Trading of
Managed Portfolio Shares and To List and Trade Shares of the Royce
Pennsylvania ETF, Royce Premier ETF, and Royce Total Return ETF Under
Proposed NYSE Arca Equities Rule 8.900

October 30, 2017.
    On April 14, 2017, NYSE Arca, Inc. (``Exchange'' or ``NYSE Arca'')
filed with the Securities and Exchange Commission (``Commission''),
pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Exchange Act'') \1\ and Rule 19b-4 thereunder,\2\ a proposed rule
change to: (1) Adopt NYSE Arca Equities Rule 8.900 (Managed Portfolio
Shares); and (2) list and trade shares of the Royce Pennsylvania ETF,
Royce Premier ETF, and Royce Total Return ETF under proposed NYSE Arca
Equities Rule 8.900. The proposed rule change was published for comment
in the Federal Register on May 4, 2017.\3\ On June 15, 2017, pursuant
to Section 19(b)(2) of the Exchange Act,\4\ the Commission designated a
longer period within which to approve the proposed rule change,
disapprove the proposed rule change, or institute proceedings to
determine whether to disapprove the proposed rule change.\5\ The
Commission received four comments on the proposed rule change.\6\ On
July 31, 2017, the Commission instituted proceedings under Section
19(b)(2)(B) of the Exchange Act \7\ to determine whether to approve or
disapprove the proposed rule change.\8\ Since then, the Commission has
received five additional comments on the proposed rule change.\9\
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ See Securities Exchange Act Release No. 80553 (April 28,
2017), 82 FR 20932.
    \4\ 15 U.S.C. 78s(b)(2).
    \5\ See Securities Exchange Act Release No. 80935, 82 FR 28152
(June 20, 2017). The Commission designated August 2, 2017, as the
date by which it should approve or disapprove, or institute
proceedings to determine whether to disapprove, the proposed rule
change.
    \6\ See Letter from Gary L. Gastineau, President, ETF
Consultants.com, Inc., to Brent J. Fields, Secretary, Commission,
dated May 24, 2017; Letter from Todd J. Broms, Chief Executive
Officer, Broms & Company LLC, to Brent J. Fields, Secretary,
Commission, dated May 25, 2017; Letter from James J. Angel,
Associate Professor of Finance, Georgetown University, McDonough
School of Business, to the Commission, dated May 25, 2017; and
Terence W. Norman, Founder, Blue Tractor Group, LLC, to Brent J.
Fields, Secretary, Commission, dated July 18, 2017. The comment
letters are available on the Commission's Web site at: https://www.sec.gov/comments/sr-nysearca-2017-36/nysearca2017-36.htm.
    \7\ 15 U.S.C. 78s(b)(2)(B).
    \8\ See Securities Exchange Act Release No. 81267, 82 FR 36510
(August 4, 2017).
    \9\ See Letter from Christopher P. Wilcox, J.P. Morgan Asset
Management, to David W. Grim, Director, Division of Investment
Management, Commission, dated July 7, 2017; Letter from Mark
Criscitello, Chairman, Precidian Funds LLC, to Brent J. Fields,
Secretary, Commission, dated October 11, 2017; Letter from Daniel J.
McCabe, Chief Executive, Precidian Investments, to Brent J. Fields,
Secretary, Commission, dated October 12, 2017; Letter from Andrew M.
Gross, Jr., to Jay Clayton, Chairman, Commission, dated October 16,
2017; and Letter from Joseph A. Sullivan, Chairman and Chief
Executive Officer, Legg Mason, Inc., to Brent J. Fields, Secretary,
Commission, dated October 12, 2017. The comment letters are
available on the Commission's Web site at: https://www.sec.gov/comments/sr-nysearca-2017-36/nysearca201736.htm.
---------------------------------------------------------------------------

    Section 19(b)(2) of the Act \10\ provides that, after initiating
proceedings, the Commission shall issue an order approving or
disapproving the proposed rule change not later than 180 days after the
date of publication of notice of filing of the proposed rule change.
The Commission, however, may extend the period for issuing an order
approving or disapproving the proposed rule change by not more than 60
days if the

Commission determines that a longer period is appropriate and publishes
the reasons for such determination. The proposed rule change was
published for notice and comment in the Federal Register on May 4,
2017.\11\ October 31, 2017, is 180 days from that date, and December
30, 2017, is an additional 60 days from that date.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78s(b)(2).
    \11\ See supra note 3.
---------------------------------------------------------------------------

    The Commission finds it appropriate to designate a longer period
within which to issue an order approving or disapproving the proposed
rule change so that it has sufficient time to consider the proposed
rule change and the issues raised in the comment letters that have been
submitted in connection therewith. Accordingly, the Commission,
pursuant to Section 19(b)(2) of the Act,\12\ designates December 30,
2017, as the date by which the Commission should either approve or
disapprove the proposed rule change (File No SR-NYSEArca-2017-36).
---------------------------------------------------------------------------

    \12\ 15 U.S.C. 78s(b)(2).

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\13\
---------------------------------------------------------------------------

    \13\ 17 CFR 200.30-3(a)(57).
---------------------------------------------------------------------------

Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2017-23923 Filed 11-2-17; 8:45 am]
BILLING CODE 8011-01-P


Explanation of Lean Burn/ Rich Burn Engine Spreadsheet Here's what each of the significant columns in the spreadsheet represents:

Account   the account number of the company found in the TCEQ permitting database Company   the name of the company Site   the name of the company's site where the engine is located County   the county where the site is located FIN   the facility identification number, or the identifier the company uses for the engine Facility Name   the name of the facility Engine Rating   the horsepower rating of the engine SCC   source classification code Description   description of the engine TPY   the reported 2002 annual emissions Activity   the activity of the engine in hp hr/ yr BEF   baseline emission factor; the uncontrolled 2002 emission factor in g/ hp hr SEF   strategic emission factor; the controlled emission factor coming into effect by June 15, 2007 Credit   the NOx reduction credit being claimed in tons per year % reduction   the percent reduction from 2002 levels Lean or Rich   the type of engine Each line the spreadsheet represents one engine. The rule only applies to 19 engines in the DFW nonattainment area. The reduction credit for each engine was calculated using the following equation:

Credit in tpy = Activity in hp hr/ yr * ( BEF in g/ hp hr   SEF in g/ hp hr) * ( 1 lb/ 453.6 g) * ( 1 ton/ 2000 lb)

The percent reduction for each engine was calculated using the following equation:

Percent reduction = ( BEF   SEF)/ BEF * 100 Once reduction credits for each engine were obtained, total annual reductions in tpy were calculated by adding up the credits for all the engines. Then total daily reductions in tpd were obtained by dividing the total annual reductions by 365. The mean percent reduction was obtained by adding the percent reduction for all the engines and dividing the result by the number of engines.


[Federal Register Volume 83, Number 182 (Wednesday, September 19, 2018)]
[Notices]
[Pages 47399-47407]
[FR Doc No: 2018-20294]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA 2018-0205]

Qualification of Drivers; Exemption Applications; Diabetes
Mellitus

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of applications for exemption; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 57 individuals
for an exemption from the prohibition in the Federal Motor Carrier
Safety Regulations (FMCSRs) against persons with insulin-treated
diabetes mellitus (ITDM) operating a commercial motor vehicle (CMV) in
interstate commerce. If granted, the exemptions would enable these
individuals with ITDM to operate CMVs in interstate commerce.

DATES: Comments must be received on or before October 19, 2018.

ADDRESSES: You may submit comments identified by the Federal Docket
Management System (FDMS) Docket No. FMCSA-2018-0205 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the online instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m.,
ET, Monday through Friday, except Federal Holidays.
     Fax: 1-202-493-2251.
    To avoid duplication, please use only one of these four methods.
See the ``Public Participation'' portion of the SUPPLEMENTARY
INFORMATION section for instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER>, [email protected], FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., ET,
Monday through Friday, except Federal holidays. If you have questions
regarding viewing or submitting material to the docket, contact Docket
Services, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Submitting Comments

    If you submit a comment, please include the docket number for this
notice (Docket No. FMCSA-2018-0205), indicate the specific section of
this document to which each comment applies, and provide a reason for
each suggestion or recommendation. You may submit your comments and
material online or by fax, mail, or hand delivery, but please use only
one of these means. FMCSA recommends that you include your name and a
mailing address, an email address, or a phone number in the body of
your document so that FMCSA can contact you if there are questions
regarding your submission.
    To submit your comment online, go to http://www.regulations.gov,
put the docket number, FMCSA 2018-0205, in the keyword box, and click
``Search.'' When the new screen appears, click on the ``Comment Now!''
button and type your comment into the text box on the following screen.
Choose whether you are submitting your comment as an individual or on
behalf of a third party and then submit.
    If you submit your comments by mail or hand delivery, submit them
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. If you submit comments by mail and would
like to know that they reached the facility, please enclose a stamped,
self-addressed postcard or envelope.
    FMCSA will consider all comments and material received during the
comment period.

B. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice
as being available in the docket, go to http://www.regulations.gov.
Insert the docket number, FMCSA 2018-0205, in the keyword box, and
click ``Search.'' Next, click the ``Open Docket Folder'' button and
choose the document to review. If you do not have access to the
internet, you may view the docket online by visiting the Docket
Management Facility in Room W12-140 on the ground floor of the DOT West
Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9
a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays.

C. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its rulemaking process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

II. Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the FMCSRs for a five-year period if it finds ``such exemption
would likely achieve a level of safety that is equivalent to or greater
than the level that would be achieved absent such exemption.'' The
statute also allows the Agency to renew exemptions at the end of the
five-year period. FMCSA grants exemptions from the FMCSRs for a two-
year period to align with the maximum duration of a driver's medical
certification.
    The 57 individuals listed in this notice have requested an
exemption from the diabetes prohibition in 49 CFR 391.41(b)(3).
Accordingly, the Agency will evaluate the qualifications of each
applicant to determine whether granting the exemption will achieve the
required level of safety mandated by statute.
    The physical qualification standard for drivers regarding diabetes
found in 49 CFR 391.41(b)(3) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control. The Agency established the current requirement for
diabetes in 1970 because several risk studies indicated that drivers
with diabetes had a higher rate of crash involvement than the general
population.
    FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. FMCSA published two notices in the Federal
Register outlining the current protocol for allowing such drivers to
operate CMVs in interstate commerce (Sep. 3, 2003, 68 FR 52441 and Nov.
8, 2005, 70 FR 67777). All of the requirements set out in the September
3, 2003, notice, except as modified by the notice in the Federal
Register on November 8, 2005, remain in effect.

III. Qualifications of Applicants

Joseph J. Arena, Jr

    Mr. Arena, 63, has had ITDM since 2015. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Arena understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Arena meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

Daniel C. Avants

    Mr. Avants, 55, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Avants understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Avants meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Washington.

Danny Bailey

    Mr. Bailey, 60, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Bailey understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Bailey meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist

examined him in 2018 and certified that he does not have diabetic
retinopathy. He holds a Class A CDL from Texas.

Ryan P. Bankert

    Mr. Bankert, 41, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Bankert understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Bankert meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

Jordan D. Braun

    Mr. Braun, 26, has had ITDM since 2003. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Braun understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Braun meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Minnesota.

David W. Buckley

    Mr. Buckley, 57, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Buckley understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Buckley meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Connecticut.

Travis R. Capesius

    Mr. Capesius, 21, has had ITDM since 2005. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Capesius understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Capesius meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Iowa.

Delquan S. Carter

    Mr. Carter, 28, has had ITDM since 2011. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Carter understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Carter meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Alabama.

Christopher J. Epplin

    Mr. Epplin, 33, has had ITDM since 1999. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Epplin understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Epplin meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Illinois.

Eugenio Esparza, Jr

    Mr. Esparza, 52, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Esparza understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Esparza meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Texas.

Brian L. Fairchild

    Mr. Fairchild, 52, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Fairchild understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Fairchild meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Idaho.

Stephen A. Fleming

    Mr. Fleming, 49, has had ITDM since 1979. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Fleming understands
diabetes management and monitoring, has stable control of his diabetes
using

insulin, and is able to drive a CMV safely. Mr. Fleming meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Minnesota.

Luigi Forcellati

    Mr. Forcellati, 76, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Forcellati understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Forcellati meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he has stable
nonproliferative diabetic retinopathy. He holds an operator's license
from New Jersey.

Daniel J. Garcia

    Mr. Garcia, 21, has had ITDM since 2015. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Garcia understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Garcia meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from California.

Derek A. Garibay

    Mr. Garibay, 52, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Garibay understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Garibay meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Colorado.

Caleb K. George

    Mr. George, 53, has had ITDM since 1996. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. George understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. George meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Rhode Island.

Dylan M. Graham

    Mr. Graham, 25, has had ITDM since 1997. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Graham understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Graham meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Michigan.

Donald D. Gueiss

    Mr. Gueiss, 51, has had ITDM since 2009. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Gueiss understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Gueiss meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds an operator's license from North
Carolina.

Michael W. Hammarsten

    Mr. Hammarsten, 65, has had ITDM since 2014. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Hammarsten understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Hammarsten meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Minnesota.

Robert L. Howell

    Mr. Howell, 67, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Howell understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Howell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds a class A CDL from Illinois.

Mitchell M. Huston

    Mr. Huston, 58, has had ITDM since 2014. His endocrinologist
examined him in 2018 and certified that he has had no

severe hypoglycemic reactions resulting in loss of consciousness,
requiring the assistance of another person, or resulting in impaired
cognitive function that occurred without warning in the past 12 months
and no recurrent (two or more) severe hypoglycemic episodes in the last
five years. His endocrinologist certifies that Mr. Huston understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Huston meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Colorado.

Daniel J. Hutt

    Mr. Hutt, 48, has had ITDM since 2002. His endocrinologist examined
him in 2018 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. Hutt understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Hutt meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined
him in 2018 and certified that he has stable nonproliferative diabetic
retinopathy. He holds a Class B CDL from New York.

Curtis C. Jacobs

    Mr. Jacobs, 56, has had ITDM since 2014. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Jacobs understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Jacobs meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from North
Carolina.

Steven M. Johnson

    Mr. Johnson, 48, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Johnson understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Johnson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Indiana.

Dwyanne E. Johnson

    Mr. Johnson, 36, has had ITDM since 2012. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Johnson understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Johnson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Colorado.

Christopher L. Johnston

    Mr. Johnston, 50, has had ITDM since 2016. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Johnston understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Johnston meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Georgia.

Gregory E. Jondle

    Mr. Jondle, 30, has had ITDM since 2010. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Jondle understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Jondle meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Iowa.

Steven Kinkead

    Mr. Kinkead, 57, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Kinkead understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Kinkead meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Missouri.

Alexander P. Laatz

    Mr. Laatz, 24, has had ITDM since 1998. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Laatz understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Laatz meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that

he does not have diabetic retinopathy. He holds an operator's license
from Virginia.

David L. Lennie

    Mr. Lennie, 71, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Lennie understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Lennie meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Michigan.

Philip J. Linn

    Mr. Linn, 65, has had ITDM since 2010. His endocrinologist examined
him in 2018 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. Linn understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Linn meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2018 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Ohio.

Raul Martinez

    Mr. Martinez, 60, has had ITDM since 2014. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Martinez understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Martinez meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Texas.

Lance E. May

    Mr. May, 46, has had ITDM since 2018. His endocrinologist examined
him in 2018 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. May understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. May meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2018 and certified that he does not have diabetic retinopathy. He
holds a Class B CDL from Pennsylvania.

Terry A. McCoy

    Mr. McCoy, 60, has had ITDM since 2016. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. McCoy understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. McCoy meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds an operator's license from Georgia.

Brian K. McGowan

    Mr. McGowan, 54, has had ITDM since 2013. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. McGowan understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. McGowan meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Arkansas.

Michael D. Mervenne

    Mr. Mervenne, 56, has had ITDM since 2008. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Mervenne understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Mervenne meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds an operator's license from
Michigan.

Kendrick D. Miller

    Mr. Miller, 41, has had ITDM since 2013. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Miller understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Miller meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from North
Carolina.

William D. Murphy

    Mr. Murphy, 48, has had ITDM since 2016. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist

certifies that Mr. Murphy understands diabetes management and
monitoring, has stable control of his diabetes using insulin, and is
able to drive a CMV safely. Mr. Murphy meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2018 and certified that he does not have diabetic retinopathy. He
holds an operator's license from West Virginia.

Babykutty Oommen

    Mr. Oommen, 59, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Oommen understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Oommen meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds an operator's license from
Illinois.

Miguel A. Orozco

    Mr. Orozco, 61, has had ITDM since 2006. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Orozco understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Orozco meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds a Class B CDL from New Jersey.

Arthur W. Pahmeier

    Mr. Pahmeier, 61, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Pahmeier understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Pahmeier meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2016 and certified that he has stable
nonproliferative diabetic retinopathy. He holds a Class A CDL from
Indiana.

Dale W. Paul

    Mr. Paul, 23, has had ITDM since 2006. His endocrinologist examined
him in 2018 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. Paul understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Paul meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined
him in 2018 and certified that he does not have diabetic retinopathy.
He holds an operator's license from California.

Jason J. Phillips

    Mr. Phillips, 35, has had ITDM since 2007. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Phillips understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Phillips meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from New Mexico.

Robert E. Piernik

    Mr. Piernik, 63, has had ITDM since 2014. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Piernik understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Piernik meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Florida.

Luc R. Poirier

    Mr. Poirier, 53, has had ITDM since 1967. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Poirier understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Poirier meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he has stable
proliferative diabetic retinopathy. He holds an operator's license from
Michigan.

Rick M. Provo

    Mr. Provo, 64, has had ITDM since 2010. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Provo understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Provo meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Indiana.

David W. Pywell

    Mr. Pywell, 58, has had ITDM since 2015. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Pywell understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Pywell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he has stable
nonproliferative diabetic retinopathy. He holds an operator's license
from Idaho.

Nicholas A. Quairoli

    Mr. Quairoli, 34, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Quairoli understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Quairoli meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Florida.

Robert A. Raymond

    Mr. Raymond, 64, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Raymond understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Raymond meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Iowa.

Robert A. Rock, Jr.

    Mr. Rock, 51, has had ITDM since 2017. His endocrinologist examined
him in 2018 and certified that he has had no severe hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 12 months and no recurrent (two or
more) severe hypoglycemic episodes in the last five years. His
endocrinologist certifies that Mr. Rock understands diabetes management
and monitoring, has stable control of his diabetes using insulin, and
is able to drive a CMV safely. Mr. Rock meets the requirements of the
vision standard at 49 CFR 391.41(b)(10). His optometrist examined him
in 2018 and certified that he does not have diabetic retinopathy. He
holds a Class A CDL from Rhode Island.

Hector R. Rodriguez

    Mr. Rodriguez, 54, has had ITDM since 2017. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Rodriguez understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Rodriguez meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Washington.

Samuel J. Shriver

    Mr. Shriver, 67, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Shriver understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Shriver meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from West
Virginia.

Bradley A. Sundby

    Mr. Sundby, 58, has had ITDM since 2013. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Sundby understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Sundby meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2018 and certified that he has stable
proliferative diabetic retinopathy. He holds an operator's license from
South Dakota.

Clayton A. Szydel

    Mr. Szydel, 53, has had ITDM since 2018. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Szydel understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Szydel meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Wisconsin.

Jeremy R. Tatro

    Mr. Tatro, 36, has had ITDM since 2012. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Tatro understands

diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Tatro meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Ohio.

Imelda Y. Tolentino

    Ms. Tolentino, 42, has had ITDM since 2011. Her endocrinologist
examined her in 2018 and certified that she has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. Her endocrinologist certifies that Ms. Tolentino understands
diabetes management and monitoring, has stable control of her diabetes
using insulin, and is able to drive a CMV safely. Ms. Tolentino meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). Her
ophthalmologist examined her in 2018 and certified that she has stable
nonproliferative diabetic retinopathy. She holds an operator's license
from Arkansas.

Birt F. Wilkerson, Jr.

    Mr. Wilkerson, 67, has had ITDM since 2000. His endocrinologist
examined him in 2018 and certified that he has had no severe
hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 12 months and no
recurrent (two or more) severe hypoglycemic episodes in the last five
years. His endocrinologist certifies that Mr. Wilkerson understands
diabetes management and monitoring, has stable control of his diabetes
using insulin, and is able to drive a CMV safely. Mr. Wilkerson meets
the requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2018 and certified that he does not have
diabetic retinopathy. He holds an operator's license from Texas.

IV. Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the dates
section of the notice.

    Issued on: September 13, 2018.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2018-20294 Filed 9-18-18; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register: September 11, 2009 (Volume 74, Number 175)]
[Notices]
[Page 46831]
[DOCID:fr11se09-99]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

Notice of Availability of Draft Technical Standard Order (TSO)-
C166b for Extended Squitter Automatic Dependent Surveillance-Broadcast
and Traffic Information Service-Broadcast Equipment Operating on the
Radio Frequency of 1090 Megahertz (MHz)

AGENCY: Federal Aviation Administration (FAA), Department of
Transportation.

ACTION: Notice of availability and request for comment.

-----------------------------------------------------------------------

SUMMARY: The FAA is announcing the availability of and requesting
comment on proposed TSO-C166b. The Avionic Systems Branch of the
Aircraft Engineering Division, Aircraft Certification Service, FAA has
presented a proposed revision of existing TSO-C166a. RTCA, Inc. Special
Committee (SC)-186 is revising RTCA Document DO-260A, Minimum
Operational Performance Standards for 1090 MHz Extended Squitter
Automatic Dependent Surveillance-Broadcast (ADS-B) and Traffic
Information-Broadcast (TIS-B), which will become the Minimum
Performance Standard (MPS) for the proposed TSO-166b. Proposed TSO-
C166b can be found at http://www.faa.gov/aircraft/draft_docs/.
Comments may be filed electronically following instructions on the
webpage. Comments may also be filed using the addresses provided below.

DATES: Comments must be received no later than October 9, 2009.

ADDRESSES: Comments may be submitted by the above deadline to Mr. Chip
Bulger, AIR-130, Orville Wright Bldg. (FOB10A), 800 Independence
Avenue, SW., Washington, DC 20591; facsimile:<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Mr. Chip Bulger, Avionics Systems
Branch, Aircraft Engineering Division, Aircraft Certification Service,
Federal Aviation Administration, 470 L'Enfant Plaza, SW., Washington,
DC 20591; telephone<PHONE_NUMBER><EMAIL_ADDRESS>
    Issued in Washington, DC on September 8, 2009.
David W. Hempe,
Manager, Aircraft Engineering Division.
[FR Doc. E9-21953 Filed 9-10-09; 8:45 am]

BILLING CODE 4910-13-P


Good Neighbor Environmental Board Meeting

Sul Ross University

Alpine, Texas

October 24-26, 2006

AGENDA

Meeting Theme: Big Bend / El Gran Recodo

October 24, 2006

8:00 a.m.	Registration

8:30 a.m.	Welcome Remarks

		Rafael DeLeon, Director, EPA Office of Cooperative Environmental Management

		Paul Ganster, Chair, Good Neighbor Environmental Board

		Opening Remarks

		Vic Morgan, President, Sul Ross University

		Mickey Clouse, Mayor of Alpine

		Judge Val Clark Beard, Brewster County

		Self Introductions

 9:15 a.m.	Speaker Presentations Begin

	9:15 a.m. – Keynote:  Dr. Ernesto Enkerlin, President, National Commission on 		Protected Areas, Mexico

	10:00 a.m. – Keynote: Russ Whitlock , Texas National Parks State Coordinator, National 	Park Service

10:45 a.m.	Break

11:00: a.m. –   Paul Silber, private landowner - Wild & Scenic Rivers program

	11:45 a.m. - Tom Beard, Far West Texas Water Planning Region – Regional Water Planning and Water Availability

12:30 p.m.	Lunch

 2:00 p.m.	Public Comment Session, including Tenth Report Input

 2:45 p.m.	Speaker Presentations Continue

	2:45 p.m.  –   David Schanbacher, TCEQ Chief Engineer - Regional Haze in Texas

3:30 p.m.	Break

	3:45 p.m. –   Jack Schmidt, Professor, Utah State University  - The Changing Physical 				Template of our Shared Rivers

	4:30 p.m. –  Mark Briggs, World Wildlife Fund – Controlling Invasive Plants Along the Rio Grande

5:15 p.m. – Additional Business

5:30 p.m. – Day One of Meeting Ends

Good Neighbor Environmental Board Meeting

Sul Ross University

Alpine, Texas

October 24-26, 2006

(October 25, 2006  - Board Field Trip to Big Bend National Park; will include briefings from National Park Service officials and a presentation from Billy Pat Mckinney on the CEMEX El

Carmen Conservation Project, located on adjoining land in Mexico)

October 26, 2006

BUSINESS MEETING

 7:30 a.m.    Registration

 8:00 a.m.    Welcome

 8:05 a.m.    Discussion/Approval of Minutes from Last Meeting

 8:15 a.m.    Invitation for Public Input on Tenth Report Draft Recommendations

 8:30 a.m.    Selection of Meeting Locations, Dates for 2007

 9:30 a.m.    Break

10:00 a.m.   Board Member Report-outs

10:45 a.m.   Selection of Theme for Eleventh Report

11:30 a.m.   Standard Operating Procedures for Board and Council on Environmental 			Quality

12:00 Noon  Meeting Ends

 10/13/06

 PAGE

 PAGE   1